久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Virafin from Zydus Cadila priced at Rs 11,995 per dose

expresspharmaMay 12, 2021

Tag: Zydus Cadila , Virafin , COVID-19 , DCGI

As per reports, Zydus Cadila has fixed the price of Virafin, a medicine that has received EUA for COVID-19 treatment, at Rs 11,995 per dose. Reportedly, the company has commenced dispatching the drug which can reportedly reduce oxygen support in COVID-19 patients.

Virafin from Zydus Cadila priced at Rs 11,995 per dose

The Drug Controller General of India (DCGI) gave emergency authorisation for restricted use to Virafin, a single-use therapy, on April 23.

Technically known as Pegylated Interferon alpha-2b, it is used to treat moderate infection of COVID-19. The company has said, “91.15 per cent of patients treated with PegIFN were RT-PCR negative by day 7.”

Previous:Woodstock Sterile Solutions Names Oliver Vogt as VP and General Manager

Next:Kejriwal asks PM to share vaccine formula with pharma firms to ramp up manufacturing

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service